BAKER BROS ADVISORS LLC Insider Trading $BLCM BELLICUM PHARMACEUTICALS, INC

FREE EMAIL WATCHDOG

Get free email notifications about insider trading for BAKER BROS ADVISORS LLC.

  • Your email is safe with us.
  • The service is free and you can unsubscribe at any time.

General | Insider Transactions | Monthly Overview

Get the latest insider transactions of BAKER BROS ADVISORS LLC. BAKER BROS ADVISORS LLC is 10% Owner in BIOCRYST PHARMACEUTICALS INC ($BCRX) and Director in INCYTE CORP ($INCY) and Director in ALEXION PHARMACEUTICALS INC ($ALXN) and 10% Owner in IDERA PHARMACEUTICALS, INC. ($IDRA) and Director in IDERA PHARMACEUTICALS, INC. ($IDRA) and in XOMA Corp ($XOMA) and Director in ACADIA PHARMACEUTICALS INC ($ACAD) and Director in SEATTLE GENETICS INC /WA ($SGEN) and Director in GENOMIC HEALTH INC ($GHDX) and 10% Owner in BELLICUM PHARMACEUTICALS, INC ($BLCM) and 10% Owner in AQUINOX PHARMACEUTICALS, INC ($AQXP) and Director in AQUINOX PHARMACEUTICALS, INC ($AQXP) and Director in Zymeworks Inc. ($ZYME) and Director in Kodiak Sciences Inc. ($KOD) and 10% Owner in Invitae Corp ($NVTA) and Director in IGM Biosciences, Inc. ($IGMS) and 10% Owner in Atreca, Inc. ($BCEL) and in Mirati Therapeutics, Inc. ($MYG) and 10% Owner in Mirati Therapeutics, Inc. ($MYG) and Director in Talis Biomedical Corp ($TLIS) and Director in Aeglea BioTherapeutics, Inc. ($AGLE) and in RHYTHM PHARMACEUTICALS, INC. ($RYTM) and in Intellia Therapeutics, Inc. ($NTLA) and Director in BeiGene, Ltd. ($BGNE) and Director in Prelude Therapeutics Inc ($PRLD) and Director in Kiniksa Pharmaceuticals, Ltd. ($KNSA) and in HOOKIPA Pharma Inc. ($HOOK).

BAKER BROS ADVISORS LLC in BELLICUM PHARMACEUTICALS, INC

Trading Symbol: BLCM
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of BAKER BROS ADVISORS LLC: 10% Owner
Holdings: 412,246 shares
Current Value: $5,181,932
Latest Transaction: Jan 19 2018
$BLCM Market Capitalization: $335.83M
$BLCM Previous Close: $12.57

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD

Latest Insider Trading Transactions of BAKER BROS ADVISORS LLC in BELLICUM PHARMACEUTICALS, INC

1 Week2 Weeks1 Month3 Months6 Months1 Year2 Years
No. of Purchases0000000
Value of Purchases ($)0000000
No. of Sales0000000
Value of Sales ($)0000000

Sentiment: All, ACAD, AGLE, ALXN, BCEL, BGNE, BLCM, BCRX, GHDX, HOOK, IDRA, IGMS, INCY, NTLA, NVTA, KNSA, KOD, MYG, NLTX, PRLD, RYTM, SGEN, TLIS, XOMA, ZYME

Page:   1

DateTickerCompanyOwnerRelationship Transaction Code Cost ($) Shares Transaction Value ($) Total Shares % Holdings
Jan 19 2018BLCMBELLICUM PHARMACEU ...BAKER BROS. ADVISORS LP10% OwnerSellS7.914,13632,71558,13162.3 K to 58.1 K (-6.64 %)
Jan 19 2018BLCMBELLICUM PHARMACEU ...BAKER BROS. ADVISORS LP10% OwnerSellS7.91265,7082,101,6713,734,7764 M to 3.7 M (-6.64 %)
Jan 19 2018BLCMBELLICUM PHARMACEU ...BAKER BROS. ADVISORS LP10% OwnerSellS7.9125,517201,832358,671384.2 K to 358.7 K (-6.64 %)
Jan 19 2018BLCMBELLICUM PHARMACEU ...BAKER BROS. ADVISORS LP10% OwnerSellS8.124,54836,91062,26766.8 K to 62.3 K (-6.81 %)
Jan 19 2018BLCMBELLICUM PHARMACEU ...BAKER BROS. ADVISORS LP10% OwnerSellS8.12292,1682,371,1484,000,4844.3 M to 4 M (-6.81 %)
Jan 19 2018BLCMBELLICUM PHARMACEU ...BAKER BROS. ADVISORS LP10% OwnerSellS8.1228,058227,710384,188412.2 K to 384.2 K (-6.81 %)
Jan 19 2018BLCMBELLICUM PHARMACEU ...BAKER BROS. ADVISORS LP10% OwnerSellS8.633,64931,47666,81570.5 K to 66.8 K (-5.18 %)
Jan 19 2018BLCMBELLICUM PHARMACEU ...BAKER BROS. ADVISORS LP10% OwnerSellS8.63234,4372,022,2304,292,6524.5 M to 4.3 M (-5.18 %)
Jan 19 2018BLCMBELLICUM PHARMACEU ...BAKER BROS. ADVISORS LP10% OwnerSellS8.6322,514194,204412,246434.8 K to 412.2 K (-5.18 %)
Mar 28 2017BLCMBELLICUM PHARMACEU ...BAKER BROS. ADVISORS LP10% OwnerBuyP12.00151,1771,814,1244,527,0894.4 M to 4.5 M (+3.45 %)
Mar 28 2017BLCMBELLICUM PHARMACEU ...BAKER BROS. ADVISORS LP10% OwnerBuyP12.0015,489185,868434,760419.3 K to 434.8 K (+3.69 %)

Page:   1